Investigation of Bemethyl Biotransformation Pathways by Combination of LC–MS/HRMS and In Silico Methods

Bemethyl is an actoprotector, an antihypoxant, and a moderate psychostimulant. Even though the therapeutic effectiveness of bemethyl is well documented, there is a gap in knowledge regarding its metabolic products and their quantitative and qualitative characteristics. Since 2018, bemethyl is includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Belinskaia, Daria A., Savelieva, Elena I., Karakashev, Georgy V., Orlova, Olga I., Leninskii, Mikhail A., Khlebnikova, Nataliia S., Shestakova, Natalia N., Kiskina, Alexandra R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396642/
https://www.ncbi.nlm.nih.gov/pubmed/34445727
http://dx.doi.org/10.3390/ijms22169021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396642/
https://www.ncbi.nlm.nih.gov/pubmed/34445727
http://dx.doi.org/10.3390/ijms22169021

Ejemplares similares